Oncology Learning Network  

Navigate the complex landscape of oncology pathways and enhance your strategies for brand success. With many factors influencing physician cancer drug choices, we help break down the tough questions and provide the necessary answers to inform your market research projects, advisory board content, forecasting, and field team perspectives.

Based on a study conducted with 130 qualified oncologists knowledgeable about provider or payer oncology pathways, the report provides valuable insights into the importance of pathways compared to other factors influencing drug choice.
Subscribe today!

... More Info Less Info

Announcing our new business unit dedicated to delivering end-to-end medical strategy and marketing for our pharmaceutical and medical device customers.

Built on four decades of experience and hundreds of world-renowned brands, HMP Collective is the gateway into the most influential treatment providers across a range of therapeutic areas. Throughout our diverse portfolio, HMP Global has a verified audience of more than 1.2 million healthcare providers, including 500,000-plus NPIs and more than 600,000 other clinicians representing over 100 license types and 600-plus medical specialties.... More Info Less Info